SEARCH

SEARCH BY CITATION

References

  • Adachi Y, Matsubara S, Pedraza C, Ozawa M, Tsutsui J, Takamatsu H et al. (1996). Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1). Oncogene 13: 21972203.
  • Antunes G, Neville E (2000). Management of malignant pleural effusions. Thorax 55: 981983.
  • Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH et al. (2001). Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861869.
  • Caulfield JP, Reid JJ, Farquhar MG (1976). Alterations of the glomerular epithelium in acute aminonucleoside nephrosis. Evidence for formation of occluding junctions and epithelial cell detachment. Lab Invest 34: 4359.
  • Chen S, Bu G, Takei Y, Sakamoto K, Ikematsu S, Muramatsu T et al. (2007). Midkine and LDL-receptor-related protein 1 contribute to the anchorage-independent cell growth of cancer cells. J Cell Sci 120 (Pt 22): 40094015.
  • Deuel TF, Zhang N, Yeh HJ, Silos-Santiago I, Wang ZY (2002). Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway. Arch Biochem Biophys 397: 162171.
  • Diamond-Stanic MK, Romero-Aleshire MJ, Hoyer PB, Greer K, Hoying JB, Brooks HL (2011). Midkine, a heparin-binding protein, is increased in the diabetic mouse kidney postmenopause. Am J Physiol Renal Physiol 300: F139F146.
  • Eddy AA, Fogo AB (2006). Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action. J Am Soc Nephrol 17: 29993012.
  • Ezquerra L, Herradon G, Nguyen T, Silos-Santiago I, Deuel TF (2005). Midkine, a newly discovered regulator of the renin-angiotensin pathway in mouse aorta: significance of the pleiotrophin/midkine developmental gene family in angiotensin II signaling. Biochem Biophys Res Commun 333: 636643.
  • Ferrari P (2007). Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease. Nephrology (Carlton) 12: 8189.
  • Fujisawa K, Matsumoto Y, Muramatsu H, Shinzato T, Hiramatsu K, Horie K et al. (1998). Increased serum midkine levels during hemodialysis using heparin in chronic renal failure. J Biochem 123: 864869.
  • Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T (2005). Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28: 164176.
  • Hertig A, Rondeau E (2004). Role of the coagulation/fibrinolysis system in fibrin-associated glomerular injury. J Am Soc Nephrol 15: 844853.
  • Hobo A, Yuzawa Y, Kosugi T, Kato N, Asai N, Sato W et al. (2009). The growth factor midkine regulates the renin-angiotensin system in mice. J Clin Invest 119: 16161625.
  • Hoke TS, Douglas IS, Klein CL, He Z, Fang W, Thurman JM et al. (2007). Acute renal failure after bilateral nephrectomy is associated with cytokine-mediated pulmonary injury. J Am Soc Nephrol 18: 155164.
  • Horiba M, Kadomatsu K, Nakamura E, Muramatsu H, Ikematsu S, Sakuma S et al. (2000). Neointima formation in a restenosis model is suppressed in midkine-deficient mice. J Clin Invest 105: 489495.
  • Hory B, Drueke TB (1997). The parathyroid-bone axis in uremia: new insights into old questions. Curr Opin Nephrol Hypertens 6: 4048.
  • Hsueh WA, Wyne K (2011). Renin-Angiotensin-aldosterone system in diabetes and hypertension. J Clin Hypertens (Greenwich) 13: 224237.
  • Jarmalavičiūtė A, Tunaitis V, Strainienė E, Aldonytė R, Ramanavičius A, Venalis A et al. (2013). A new experimental model for neuronal and glial differentiation using stem cells derived from human exfoliated deciduous teeth. J Mol Neurosci (Epub ahead of print).
  • Johnson RJ, Feig DI, Nakagawa T, Sanchez-Lozada LG, Rodriguez-Iturbe B (2008). Pathogenesis of essential hypertension: historical paradigms and modern insights. J Hypertens 26: 381391.
  • Kadomatsu K, Muramatsu T (2004). Midkine and pleiotrophin in neural development and cancer. Cancer Lett 204: 127143.
  • Kaplan F, Comber J, Sladek R, Hudson TJ, Muglia LJ, Macrae T et al. (2003). The growth factor midkine is modulated by both glucocorticoid and retinoid in fetal lung development. Am J Respir Cell Mol Biol 28: 3341.
  • Kato K, Kosugi T, Sato W, Arata-Kawai H, Ozaki T, Tsuboi N et al. (2011). Growth factor Midkine is involved in the pathogenesis of renal injury induced by protein overload containing endotoxin. Clin Exp Nephrol 15: 346354.
  • Kawai H, Sato W, Yuzawa Y, Kosugi T, Matsuo S, Takei Y et al. (2004). Lack of the growth factor midkine enhances survival against cisplatin-induced renal damage. Am J Pathol 165: 16031612.
  • Kitching AR, Holdsworth SR, Ploplis VA, Plow EF, Collen D, Carmeliet P et al. (1997). Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med 185: 963968.
  • Kobori H, Nishiyama A, Abe Y, Navar LG (2003). Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 41: 592597.
  • Kojima H, Kosugi T, Sato W, Sato Y, Maeda K, Kato N et al. (2013). Deficiency of growth factor midkine exacerbates necrotizing glomerular injuries in progressive glomerulonephritis. Am J Pathol 182: 410419.
  • Kosugi T, Yuzawa Y, Sato W, Kawai H, Matsuo S, Takei Y et al. (2006). Growth factor midkine is involved in the pathogenesis of diabetic nephropathy. Am J Pathol 168: 919.
  • Kosugi T, Yuzawa Y, Sato W, Arata-Kawai H, Suzuki N, Kato N et al. (2007). Midkine is involved in tubulointerstitial inflammation associated with diabetic nephropathy. Lab Invest 87: 903913.
  • Kosugi T, Heinig M, Nakayama T, Connor T, Yuzawa Y, Li Q et al. (2009). Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice. Am J Pathol 174: 12211229.
  • Lauriat S, Linas SL (1998). The role of neutrophils in acute renal failure. Semin Nephrol 18: 498504.
  • Matsubara S, Take M, Pedraza C, Muramatsu T (1994). Mapping and characterization of a retinoic acid-responsive enhancer of midkine, a novel heparin-binding growth/differentiation factor with neurotrophic activity. J Biochem 115: 10881096.
  • Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M et al. (2002). Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90: E58E65.
  • Muramatsu T (1993). Midkine (MK), the product of a retinoic acid responsive gene, and pleiotrophin constitute a new protein family regulating growth and differentiation. Int J Dev Biol 37: 183188.
  • Muramatsu T (2002). Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. J Biochem 132: 359371.
  • Naicker S, Fabian J, Naidoo S, Wadee S, Paget G, Goetsch S (2007). Infection and glomerulonephritis. Semin Immunopathol 29: 397414.
  • Nakagawa T, Tanabe K, Croker BP, Johnson RJ, Grant MB, Kosugi T et al. (2011). Endothelial dysfunction as a potential contributor in diabetic nephropathy. Nat Rev Nephrol 7: 3644.
  • Navar LG, Kobori H, Prieto MC, Gonzalez-Villalobos RA (2011). Intratubular renin-angiotensin system in hypertension. Hypertension 57: 355362.
  • Nobakht N, Kamgar M, Rastogi A, Schrier RW (2011). Limitations of angiotensin inhibition. Nat Rev Nephrol 7: 356359.
  • Okubo S, Niimura F, Matsusaka T, Fogo A, Hogan BL, Ichikawa I (1998). Angiotensinogen gene null-mutant mice lack homeostatic regulation of glomerular filtration and tubular reabsorption. Kidney Int 53: 617625.
  • Padanilam BJ (2003). Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis. Am J Physiol Renal Physiol 284: F608F627.
  • Prieto-Carrasquero MC, Botros FT, Kobori H, Navar LG (2009). Collecting Duct Renin: a major player in Angiotensin II-dependent Hypertension. J Am Soc Hypertens 3: 96104.
  • Pupilli C, Chevalier RL, Carey RM, Gomez RA (1992). Distribution and content of renin and renin mRNA in remnant kidney of adult rat. Am J Physiol 263 (4 Pt 2): F731F738.
  • Qiu L, Hyink DP, Gans WH, Amsler K, Wilson PD, Burrow CR (2004). Midkine promotes selective expansion of the nephrogenic mesenchyme during kidney organogenesis. Organogenesis 1: 1421.
  • Remuzzi G, Ruggenenti P, Benigni A (1997). Understanding the nature of renal disease progression. Kidney Int 51: 215.
  • Reynolds PR, Mucenski ML, Le Cras TD, Nichols WC, Whitsett JA (2004). Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J Biol Chem 279: 3712437132.
  • Ruggenenti P, Cravedi P, Remuzzi G (2010). The RAAS in the pathogenesis and treatment of diabetic nephropathy. Nat Rev Nephrol 6: 319330.
  • Sakamoto K, Bu G, Chen S, Takei Y, Hibi K, Kodera Y et al. (2011). Premature ligand-receptor interaction during biosynthesis limits the production of growth factor midkine and its receptor LDL receptor-related protein 1. J Biol Chem 286: 84058413.
  • Satarug S, Baker JR, Reilly PE, Esumi H, Moore MR (2000). Evidence for a synergistic interaction between cadmium and endotoxin toxicity and for nitric oxide and cadmium displacement of metals in the kidney. Nitric Oxide 4: 431440.
  • Sato W, Kadomatsu K, Yuzawa Y, Muramatsu H, Hotta N, Matsuo S et al. (2001). Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury. J Immunol 167: 34633469.
  • Sato W, Yuzawa Y, Kadomatsu K, Tayasu T, Muramatsu H, Muramatsu T et al. (2002). Midkine expression in the course of nephrogenesis and its role in ischaemic reperfusion injury. Nephrol Dial Transplant 17 (Suppl 9): 5254.
  • Sato W, Takei Y, Yuzawa Y, Matsuo S, Kadomatsu K, Muramatsu T (2005). Midkine antisense oligodeoxyribonucleotide inhibits renal damage induced by ischemic reperfusion. Kidney Int 67: 13301339.
  • Schrier RW, Wang W, Poole B, Mitra A (2004). Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 114: 514.
  • Shibata R, Ueda S, Yamagishi S, Kaida Y, Matsumoto Y, Fukami K et al. (2009). Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy. Nephrol Dial Transplant 24: 11621169.
  • Suzuki A, Ito T, Imai E, Yamato M, Iwatani H, Kawachi H et al. (2003). Retinoids regulate the repairing process of the podocytes in puromycin aminonucleoside-induced nephrotic rats. J Am Soc Nephrol 14: 981991.
  • Takada J, Ooboshi H, Ago T, Kitazono T, Yao H, Kadomatsu K et al. (2005). Postischemic gene transfer of midkine, a neurotrophic factor, protects against focal brain ischemia. Gene Ther 12: 487493.
  • Tsutsui J, Uehara K, Kadomatsu K, Matsubara S, Muramatsu T (1991). A new family of heparin-binding factors: strong conservation of midkine (MK) sequences between the human and the mouse. Biochem Biophys Res Commun 176: 792797.
  • Vilar J, Lalou C, Duong Van Huyen JP, Charrin S, Hardouin S, Raulais D et al. (2002). Midkine is involved in kidney development and in its regulation by retinoids. J Am Soc Nephrol 13: 668676.
  • Vinik A, Ullal J, Parson HK, Casellini CM (2006). Diabetic neuropathies: clinical manifestations and current treatment options. Nat Clin Pract Endocrinol Metab 2: 269281.
  • Zhang W, Chen X, Shi S, Wei R, Wang J, Yamanaka N et al. (2005). Expression and activation of STAT3 in chronic proliferative immune complex glomerulonephritis and the effect of fosinopril. Nephrol Dial Transplant 20: 892901.